Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
9.98
+1.11 (12.51%)
At close: Jun 3, 2026, 4:00 PM EDT
9.72
-0.26 (-2.61%)
Pre-market: Jun 4, 2026, 7:03 AM EDT
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $824.07 million as of June 4, 2026. Its market cap has increased by 30.49% in one year.
Market Cap
824.07M
Enterprise Value
631.28M
1-Year Change
30.49%
Ranking
Category
Stock Price
$9.98
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $824.07M, an increase of 76.27%. That is a compound annual growth rate of 7.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 824.07M | 8.08% |
| Dec 31, 2025 | 762.47M | -18.18% |
| Dec 31, 2024 | 931.93M | 87.18% |
| Dec 29, 2023 | 497.87M | -67.63% |
| Dec 30, 2022 | 1.54B | 21.04% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 859.29M |
| Xencor | 846.70M |
| Janux Therapeutics | 828.78M |
| Lexicon Pharmaceuticals | 821.76M |
| Theravance Biopharma | 820.21M |
| Inventiva | 817.33M |
| ORIC Pharmaceuticals | 811.58M |
| LB Pharmaceuticals | 801.51M |